CelsoTelloMD

Ophthalmology • New York, NY

Cataract Related, Glaucoma Related, Retinal Disease

Chairman, Department of Ophthalmology Manhattan Eye, Ear & Throat Hospital and Professor of Ophthalmology, Northwell School of Medicine

Join to view full profile

Dr. Tello is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tello's full profile

Already have an account?

Office
210 East 64th Street
7th Floor
New York, NY 10065
Phone+1 212-702-7300

Fax+1 212-702-7670

Summary

I am a board certified Ophthalmologist with special interest in Glaucoma and Cataract surgery

Northwell Health

Northwell Health (formerly North Shore-LIJ) is a network of 61,000 healers and innovators committed to changing health care for the better.

Clinical Expertise

Cataract surgery, Glaucoma and related disorders, Vision disorders, Visual field testing

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Glaucoma, 1998 - 1999
Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Ophthalmology, 1995 - 1998
St Barnabas Medical CenterInternship, Transitional Year, 1994 - 1995
University of Cuenca Faculty of Medical ScienceClass of 1988

Certifications & Licensure

NY State Medical License 1997 - 2025
NJ State Medical License 1999 - 2009
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow American College of Surgeons ACS, 2016-2017
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
Super Doctor SuperDoctors.com
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Shunt Tube Exposure Prevention Study Start of enrollment: 2013 Jun 01
Completed
Not Applicable
A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma Start of enrollment: 2014 May 01
Unknown status
Phase 2
A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt Start of enrollment: 2014 Jun 01
Unknown status
Phase 2

Publications & Presentations

PubMed

Diagnostic Capability of Pattern Electroretinogram and Three Circumpapillary Retinal Nerve Fiber Layer Thickness Circle Diameter Scans in Glaucoma Suspects.
Andrew Tirsi, Joby Tsai, Aaron Abizadeh, Danielle Kacaj, Oksana Procyk
Clinical Ophthalmology. 2025-01-01
2 citations
180- Versus 360-Degree Selective Laser Trabeculoplasty in Open Angle Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis.
Daniel Zhu, Paras P Shah, Amanda Wong, Charles Zhang, Daniel Barmas-Alamdari
Journal of Glaucoma. 2024-08-01
3 citations
Retinal Ganglion Cell Functional Recovery after Intraocular Pressure Lowering Treatment Using Prostaglandin Analogs in Glaucoma Suspects: A Prospective Pilot Study.
Andrew Tirsi, Vasiliki Gliagias, Hosam Sheha, Bhakti Patel, Julie Moehringer
Journal of Current Glaucoma Practice. 2024-01-25

Press Mentions

Pattern Electroretinogram Parameters and Their AssociationsSeptember 21st, 2022

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Other Languages

Spanish, Portuguese